Abstract:At present, more than 30 million low-birth-weight (LBW) infants are born annually (23.8% of all births) worldwide. Those LBW infants are significantly more susceptible to other infections and have a higher risk of dying during infancy. It is generally agreed that maternal nutrition and social-economic status are the main risk factors underlying the pathology of LBW. Recent animal data show that LBW is the most sensitive endpoint of developmental toxicity some environmental endocrine disruptors (EEDs), such as di-n-butyl phthalate (DBP). Therefore, the present study was designed to investigate the relationship between phthalates exposure and LBW in humans, using a case-controlled panel study of a population in Shanghai, China. From Jan. 2006 through Jan. 2007, 201 consecutive newborns (including 88 term LBW newborns as cases, and 113 term infants as controls), delivered at Shanghai Healthcare Center for Maternal and Children, were investigated by questionnaires. All participants signed the written informed consents for attending this case-control study. We analyzed maternal and umbilical cord blood for four kinds of phthalates (di-2-ethylhexyl phthalate, DEHP; mono-2-ethylhexyl phthalate, MEHP; di-ethyl phthalate, DEP; di-n-butyl phthalate, DBP) by the method of liquid chromatography-mass spectrometry (LC-MS). The binomial Logistic regression, Spearman correlation and linear regression methods were used to analyze the potential risk factors of LBW and their relationship with phthalates exposure. Among seventy factors we investigated in questionnaires, multivariate models showed that there were only three risk factors (presence of cord loops, dysmenorrheal history, and source of drink water) which have significantly related with LBW (P£¼0.05). Furthermore, maternal diseases before pregnancy and during gestation were also found to have negative association with birth length of newborns. Above 70% of serum samples had quantifiable levels of phthalates in maternal-infant pairs of case and control group. The levels of these chemicals in maternal blood samples were higher than those in cord blood of their newborns. Statistically, there are significantly higher levels of phthalates in cord blood serum in LBW infants than those of the controls (2.0mg/L vs. 1.9mg/L for DEP, 2.55mg/L vs. 2.02mg/L for DBP, 0,74mg/L vs. 0.63mg/L for DEHP, 2.50mg/L vs. 1.27mg/L for MEHP). Moreover, there was a significant correlation between the birth weight and the levels of DBP and MEHP (P<0.001). The present results showed that phthalates and their metabolites could pass the blood-placenta barriers in humans. Phthalates exposure, especially DBP and DEHP in drink water, might be potential environmental risk factors of low birth weight in newborns. This research was supported by Natural Science Foundation of China No.30500397 (Y.H.Z.) and in part by the Bixby Foundation (Y.H.Z.).

Meconium Exposure to Phthalates, Sex and Thyroid Hormones, Birth Size and Pregnancy Outcomes in 251 Mother–Infant Pairs from Shanghai

Phthalate metabolites in meconium and their associations with hormones in cord blood

Association between phthalate metabolite mixture in neonatal cord serum and birth outcomes

Relationship Between Maternal Phthalate Exposure and Offspring Size at Birth

Phthalate Levels and Low Birth Weight: A Nested Case-Control Study of Chinese Newborns

Association Between Prenatal Phthalate Exposure and Birth Outcomes

Prenatal Phthalate Exposure and Birth Size: a Systematic Review and Meta-Analysis.

Maternal Exposure of Phthalates in Low-Birth-Weight Newborns: A Case-Control Study in Shanghai, China.

The sex-specific association of prenatal phthalate exposure with low birth weight and small for gestational age: A nationwide survey by the Taiwan Maternal and Infant Cohort Study (TMICS)

Relationship of individual and mixed prenatal phthalate exposure with placental structure and efficiency in the prospective Ma'anshan Birth Cohort Study

Gender-specific relationship between prenatal exposure to phthalates and intrauterine growth restriction

Effects of Prenatal Phthalate Exposure on Thyroid Hormone Concentrations Beginning at the Embryonic Stage

Effects of single and combined gestational phthalate exposure on blood pressure, blood glucose and gestational weight gain: A longitudinal analysis

The Exposure Levels of Phthalates in Pregnant Women and Impact Factors of Fetal Malformation

Evaluating Effects of Prenatal Exposure to Phthalates on Neonatal Birth Weight: Structural Equation Model Approaches.

Prenatal Exposure to Phthalates and Neurocognitive Development in Children at Two Years of Age

Effects of Prenatal Exposure to Phthalates on Neonatal Birth Weight: SHK Birth Cohort

Associations Between Phthalate Exposure and Thyroid Function in Pregnant Women During the First Trimester.

Phthalate Exposure and Cumulative Risk in a Chinese Newborn Population

Assessment on cumulative health risk of phthalic acid esters in meconium of 237 Shanghai newborns

Urinary phthalate metabolites in pregnant women: occurrences, related factors, and association with maternal hormones